Adeno-associated viral vectors for retinal gene transfer

Progress in Retinal and Eye Research

Volumn 22, Issue 6, 2003, Pages 705-719

  Surace, Enrico M ^a   Auricchio, Alberto ^a  

^a TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

Author keywords

AAV; Ocular neovascularization; Retinitis pigmentosa

Indexed keywords

4 SULFATASE; ADENOVIRUS VECTOR; ANGIOGENESIS INHIBITOR; ANGIOSTATIN; BETA GLUCURONIDASE; CATALASE; CILIARY NEUROTROPHIC FACTOR; CYTOKINE; ENDOSTATIN; ERYTHROPOIETIN; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 5; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GROWTH FACTOR; MATRIX METALLOPROTEINASE; NEUROTROPHIC FACTOR; PERIPHERIN; PIGMENT EPITHELIUM DERIVED FACTOR; RIBOZYME; SULFATASE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ADENOVIRUS; CELL DIVISION; CELL TYPE; CELLULAR IMMUNITY; DISEASE MODEL; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENE MUTATION; GENE TARGETING; GENE TRANSFER; GENETIC CODE; GENETIC TRANSDUCTION; HUMAN; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; RETINA; RETINA CELL; RETINA DEGENERATION; RETINA DISEASE; RETINA NEOVASCULARIZATION; REVIEW; SEROTYPE; STRUCTURE ANALYSIS; TARGET CELL; VIRAL GENE DELIVERY SYSTEM; VIRION; VIRUS GENE;

EID: 0142090629     PISSN: 13509462     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1350-9462(03)00052-1     Document Type: Review

References (158)

1. Acland G.M., Aguirre G.D., Ray J., Zhang Q., Aleman T.S., Cideciyan A.V., Pearce-Kelling S.E., Anand V., Zeng Y., Maguire A.M., Jacobson S.G., Hauswirth W.W., Bennett J. Gene therapy restores vision in a canine model of childhood blindness. Nat. Genet. 28:2001;92-95.
2. Ali R.R., Reichel M.B., Thrasher A.J., Levinsky R.J., Kinnon C., Kanuga N., Hunt D.M., Bhattacharya S.S. Gene transfer into the mouse retina mediated by an adeno-associated viral vector. Hum. Mol. Genet. 5:1996;591-594.
3. Ali R.R., Reichel M.B., De Alwis M., Kanuga N., Kinnon C., Levinsky R.J., Hunt D.M., Bhattacharya S.S., Thrasher A.J. Adeno-associated virus gene transfer to mouse retina. Hum. Gene Ther. 9:1998;81-86.
4. Ali R.R., Sarra G.M., Stephens C., Alwis M.D., Bainbridge J.W., Munro P.M., Fauser S., Reichel M.B., Kinnon C., Hunt D.M., Bhattacharya S.S., Thrasher A.J. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat. Genet. 25:2000;306-310.
5. Anand V., Chirmule N., Fersh M., Maguire A.M., Bennett J. Additional transduction events after subretinal readministration of recombinant adeno-associated virus. Hum. Gene Ther. 11:2000;449-457.
6. Anand V., Duffy B., Yang Z., Dejneka N.S., Maguire A.M., Bennett J. A deviant immune response to viral proteins and transgene product is generated on subretinal administration of adenovirus and adeno-associated virus. Mol. Ther.: J. Am. Soc. Gene Ther. 5:2002;125-132.
7. Auricchio A., Kobinger G., Anand V., Hildinger M., O'Connor E., Maguire A.M., Wilson J.M., Bennett J. Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics. the retina as a model Hum. Mol. Gene. 10:2001;3075-3081.
8. Auricchio A., Behling K.C., Maguire A.M., O'Connor E.M., Bennett J., Wilson J.M., Tolentino M.J. Inhibition of retinal neovascularization by intraocular viral-mediated delivery of anti-angiogenic agents. Mol. Ther. 6:2002;490-494.
9. Auricchio A., O'Connor E., Weiner D., Gao G.P., Hildinger M., Wang L., Calcedo R., Wilson J.M. Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins. J. Clin. Invest. 110:2002;499-504.
10. Auricchio A., Rivera V.M., Clackson T., O'Connor E.E., Maguire A.M., Tolentino M.J., Bennett J., Wilson J.M. Pharmacological regulation of protein expression from adeno-associated viral vectors in the eye. Mol. Ther.: J. Am. Soc. Gene Ther. 6:2002;238-242.
11. Bainbridge J.W., Mistry A., De Alwis M., Paleolog E., Baker A., Thrasher A.J., Ali R.R. Inhibition of retinal neovascularisation by gene transfer of soluble vegf receptor sFlt-1. Gene Ther. 9:2002;320-326.
12. Banin E., Cideciyan A.V., Aleman T.S., Petters R.M., Wong F., Milam A.H., Jacobson S.G. Retinal rod photoreceptor-specific gene mutation perturbs cone pathway development. Neuron. 23:1999;549-557.
13. Bantel-Schaal U., zur Hausen H. Characterization of the DNA of a defective human parvovirus isolated from a genital site. Virology. 134:1984;52-63.
14. Bantel-Schaal U., Delius H., Schmidt R., zur Hausen H. Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses. J. Virol. 73:1999;939-947.
15. Bartlett J.S., Kleinschmidt J., Boucher R.C., Samulski R.J. Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F (ab'gamma)2 antibody. Nat. Biotechnol. 17:1999;181-186.
16. Bennett J. Gene therapy for retinitis pigmentosa. Curr. Opin. Mol. Therapeutics. 2:2000;420-425.
17. Bennett J., Maguire A.M. Gene therapy for ocular disease. Mol. Ther.: J. Am. Soc. Gene Ther. 1:2000;501-505.
18. Bennett J., Pakola S., Zeng Y., Maguire A. Humoral response after administration of E1-deleted adenoviruses. immune privilege of the subretinal space Hum. Gene Ther. 7:1996;1763-1769.
19. Bennett J., Duan D., Engelhardt J.F., Maguire A.M. Real-time, noninvasive in vivo assessment of adeno-associated virus- mediated retinal transduction. Invest. Ophthalmol. Vis. Sci. 38:1997;2857-2863.
20. Bennett J., Zeng Y., Bajwa R., Klatt L., Li Y., Maguire A.M. Adenovirus-mediated delivery of rhodopsin-promoted bcl-2 results in a delay in photoreceptor cell death in the rd/rd mouse. Gene Ther. 5:1998;1156-1164.
21. Bennett J., Maguire A.M., Cideciyan A.V., Schnell M., Glover E., Anand V., Aleman T.S., Chirmule N., Gupta A.R., Huang Y., Gao G.P., Nyberg W.C., Tazelaar J., Hughes J., Wilson J.M., Jacobson S.G. Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc. Natl. Acad. Sci. USA. 96:1999;9920-9925.
22. Bennett J., Maguire A.M., Cideciyan A.V., Schnell M., Glover E., Anand V., Aleman T.S., Chirmule N., Gupta A.R., Huang Y., Gao G.P., Nyberg W.C., Tazelaar J., Hughes J., Wilson J.M., Jacobson S.G. Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc. Natl. Acad. Sci. USA. 96:1999;9920-9925.
23. Berns K.I. Paroviridae. the viruses and their replication Fields B.N. Fundamental Virology. 1996;1017-1042 Lippincot-Raven. Philadelphia, New York.
24. Bok D., Yasumura D., Matthes M.T., Ruiz A., Duncan J.L., Chappelow A.V., Zolutukhin S., Hauswirth W., LaVail M.M. Effects of adeno-associated virus-vectored ciliary neurotrophic factor on retinal structure and function in mice with a P216L rds/peripherin mutation. Exp. Eye Res. 74:2002;719-735.
25. Bok D., Yasumura D., Matthes M.T., Ruiz A., Duncan J.L., Chappelow A.V., Zolutukhin S., Hauswirth W., LaVail M.M. Effects of adeno-associated virus-vectored ciliary neurotrophic factor on retinal structure and function in mice with a P216L rds/peripherin mutation. Exp. Eye Res. 74:2002;719-735.
26. Campochiaro P.A. Retinal and choroidal neovascularization. J. Cell Physiol. 184:2000;301-310.
27. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature. 407:2000;249-257.
28. Cayouette M., Behn D., Sendtner M., Lachapelle P., Gravel C. Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse. J. Neurosci. 18:1998;9282-9293.
29. Chang B., Hawes N.L., Hurd R.E., Davisson M.T., Nusinowitz S., Heckenlively J.R. Retinal degeneration mutants in the mouse. Vision Res. 42:2002;517-525.
30. Chang G.Q., Hao Y., Wong F. Apoptosis. final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice Neuron. 11:1993;595-605.
31. Chao H., Samulski R., Bellinger D., Monahan P., Nichols T., Walsh C. Persistent expression of canine factor IX in hemophilia B canines. Gene Ther. 6:1999;1695-1704.
32. Chao H., Liu Y., Rabinowitz J., Li C., Samulski R.J., Walsh C.E. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol. Ther. 2:2000;619-623.
33. Chen J., Flannery J.G., LaVail M.M., Steinberg R.H., Xu J., Simon M.I. bcl-2 overexpression reduces apoptotic photoreceptor cell death in three different retinal degenerations. Proc. Natl. Acad. Sci. USA. 93:1996;7042-7047.
34. Chiorini J.A., Kim F., Yang L., Kotin R.M. Cloning and characterization of adeno-associated virus type 5. J. Virol. 73:1999;1309-1319.
35. Cremers F.P., van den Hurk J.A., den Hollander A.I. Molecular genetics of Leber congenital amaurosis. Hum. Mol. Genet. 11:2002;1169-1176.
36. Daly T.M., Vogler C., Levy B., Haskins M.E., Sands M.S. Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease. Proc. Natl. Acad. Sci. USA. 96:1999;2296-2300.
37. Davidson B.L., Stein C.S., Heth J.A., Martins I., Kotin R.M., Derksen T.A., Zabner J., Ghodsi A., Chiorini J.A. Recombinant adeno-associated virus type 2, 4 and 5 vectors. transduction of variant cell types and regions in the mammalian central nervous system Proc. Natl. Acad. Sci. USA. 97:2000;3428-3432.
38. Dejneka N.S., Bennett J. Gene therapy and retinitis pigmentosa. advances and future challenges Bioessays. 23:2001;662-668.
39. Dejneka N.S., Auricchio A., Maguire A.M., Ye X., Gao G.P., Wilson J.M., Bennett J. Pharmacologically regulated gene expression in the retina following transduction with viral vectors. Gene Ther. 8:2001;442-446.
40. Doudna J.A., Cech T.R. The chemical repertoire of natural ribozymes. Nature. 418:2002;222-228.
41. Duan D., Fisher K.J., Burda J.F., Engelhardt J.F. Structural and functional heterogeneity of integrated recombinant AAV genomes. Virus Res. 48:1997;41-56.
42. Duan D., Yan Z., Yue Y., Ding W., Engelhardt J.F. Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation. J. Virol. 75:2001;7662-7671.
43. Duan D., Yue Y., Engelhardt J.F. Expanding AAV packaging capacity with trans-splicing or overlapping vectors. a quantitative comparison Mol. Ther. 4:2001;383-391.
44. Duan D., Yue Y., Engelhardt J.F. Dual vector expansion of the recombinant AAV packaging capacity. Methods Mol. Biol. 219:2003;29-51.
45. Duan D., Yue Y., Yan Z., Engelhardt J.F. Trans-splicing vectors expand the packaging limits of adeno-associated virus for gene therapy applications. Methods Mol. Med. 76:2003;287-307.
46. Dudus L., Anand V., Acland G.M., Chen S.J., Wilson J.M., Fisher K.J., Maguire A.M., Bennett J. Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV. Vision Res. 39:1999;2545-2553.
47. During M.J., Xu R., Young D., Kaplitt M.G., Sherwin R.S., Leone P. Peroral gene therapy of lactose intolerance using an adeno-associated virus vector. Nat. Med. 4:1998;1131-1135.
48. During M.J., Symes C.W., Lawlor P.A., Lin J., Dunning J., Fitzsimons H.L., Poulsen D., Leone P., Xu R., Dicker B.L., Lipski J., Young D. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science. 287:2000;1453-1460.
49. Farrar G.J., Kenna P.F., Humphries P. On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention. EMBO J. 21:2002;857-864.
50. Flannery J.G., Zolotukhin S., Vaquero M.I., LaVail M.M., Muzyczka N., Hauswirth W.W. Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc. Natl. Acad. Sci. USA. 94:1997;6916-6921.
51. Fraites T.J. Jr., Schleissing M.R., Shanely R.A., Walter G.A., Cloutier D.A., Zolotukhin I., Pauly D.F., Raben N., Plotz P.H., Powers S.K., Kessler P.D., Byrne B.J. Correction of the enzymatic and functional deficits in a model of Pompe disease using adeno-associated virus vectors. Mol. Ther. 5:2002;571-578.
52. Fu H., Samulski R.J., McCown T.J., Picornell Y.J., Fletcher D., Muenzer J. Neurological correction of lysosomal storage in a mucopolysaccharidosis IIIB mouse model by adeno-associated virus-mediated gene delivery. Mol. Ther. 5:2002;42-49.
53. Gao G.P., Alvira M.R., Wang L., Calcedo R., Johnston J., Wilson J.M. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA. 99:2002;11854-11859.
54. Girod A., Ried M., Wobus C., Lahm H., Leike K., Kleinschmidt J., Deleage G., Hallek M. Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2. Nat. Med. 5:1999;1052-1056.
55. Goldberg A.F., Molday R.S. Defective subunit assembly underlies a digenic form of retinitis pigmentosa linked to mutations in peripherin/rds and rom-1. Proc. Natl. Acad. Sci. USA. 93:1996;13726-13730.
56. Goldberg A.F., Molday R.S. Subunit composition of the peripherin/rds-rom-1 disk rim complex from rod photoreceptors. hydrodynamic evidence for a tetrameric quaternary structure Biochemistry. 35:1996;6144-6149.
57. Green E.S., Rendahl K.G., Zhou S., Ladner M., Coyne M., Srivastava R., Manning W.C., Flannery J.G. Two animal models of retinal degeneration are rescued by recombinant adeno-associated virus-mediated production of FGF-5 and FGF-18. Mol. Ther. 3:2001;507-515.
58. Gregory-Evans, K. An eye for an eye: new models of genetic ocular disease [comment].
59. Guy J., Qi X., Hauswirth W.W. Adeno-associated viral-mediated catalase expression suppresses optic neuritis in experimental allergic encephalomyelitis. Proc. Natl. Acad. Sci. USA. 95:1998;13847-13852.
60. Guy J., Qi X., Muzyczka N ., Hauswirth W.W. Reporter expression persists 1 year after adeno-associated virus-mediated gene transfer to the optic nerve. Arch. Ophthalmol. 117:1999;929-937.
61. Guy J., Qi X., Pallotti F., Schon E.A., Manfredi G., Carelli V., Martinuzzi A., Hauswirth W.W., Lewin A.S. Rescue of a mitochondrial deficiency causing Leber Hereditary Optic Neuropathy. Ann. Neurol. 52:2002;534-542.
62. Hao W., Wenzel A., Obin M.S., Chen C.K., Brill E., Krasnoperova N.V., Eversole-Cire P., Kleyner Y., Taylor A., Simon M.I., Grimm C., Reme C.E., Lem J. Evidence for two apoptotic pathways in light-induced retinal degeneration. Nat. Genet. 32:2002;254-260.
63. Harada T., Harada C., Nakayama N., Okuyama S., Yoshida K., Kohsaka S., Matsuda H., Wada K. Modification of glial-neuronal cell interactions prevents photoreceptor apoptosis during light-induced retinal degeneration. Neuron. 26:2000;533-541.
64. Harvey A.R., Kamphuis W., Eggers R., Symons N.A., Blits B., Niclou S., Boer G.J., Verhaagen J. Intravitreal injection of adeno-associated viral vectors results in the transduction of different types of retinal neurons in neonatal and adult rats. a comparison with lentiviral vectors Mol. Cell. Neurosci. 21:2002;141-157.
65. Haskins M.E., Jezyk P.F., Desnick R.J., McGovern M.M., Vine D.T., Patterson D.F. Animal models of mucopolysaccharidosis. Prog. Clin. Biol. Res. 94:1982;177-201.
66. Hauswirth W.W., Lewin A.S. Ribozyme uses in retinal gene therapy. Prog. Ret. Eye Res. 19:2000;689-710.
67. Hawkins R.K., Jansen H.G., Sanyal S. Development and degeneration of retina in rds mutant mice. photoreceptor abnormalities in the heterozygotes Exp. Eye Res. 41:1985;701-720.
68. Hengge U.R., Mirmohammadsadegh A. Adeno-associated virus expresses transgenes in hair follicles and epidermis. Mol. Ther. 2:2000;188-194.
69. Herzog R.W., Hagstrom J.N., Kung S.H., Tai S.J., Wilson J.M., Fisher K.J., High K.A. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc. Natl. Acad. Sci. USA. 94:1997;5804-5809.
70. Hildinger M., Auricchio A., Gao G., Wang L., Chirmule N., Wilson J.M. Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J. Virol. 75:2001;6199-6203.
71. Ho T.T., Maguire A.M., Aguirre G.D., Surace E.M., Anand V., Zeng Y., Salvetti A., Hopwood J.J., Haskins M.E., Bennett J. Phenotypic rescue after adeno-associated virus-mediated delivery of 4-sulfatase to the retinal pigment epithelium of feline mucopolysaccharidosis VI. J. Gene Med. 4:2002;613-621.
72. Hoshijima M., Ikeda Y., Iwanaga Y., Minamisawa S., Date M.O., Gu Y., Iwatate M., Li M., Wang L., Wilson J.M., Wang Y., Ross J. Jr., Chien K.R. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat. Med. 8:2002;864-871.
73. Huang Z.J., Kirkwood A., Pizzorusso T., Porciatti V., Morales B., Bear M.F., Maffei L., Tonegawa S. BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell. 98:1999;739-755.
74. Inoue N., Hirata R.K., Russell D.W. High-fidelity correction of mutations at multiple chromosomal positions by adeno-associated virus vectors. J. Virol. 73:1999;7376-7380.
75. Inoue N., Dong R., Hirata R.K., Russell D.W. Introduction of single base substitutions at homologous chromosomal sequences by adeno-associated virus vectors. Mol. Ther. 3:2001;526-530.
76. Janson C., McPhee S., Bilaniuk L., Haselgrove J., Testaiuti M., Freese A., Wang D.J., Shera D., Hurh P., Rupin J., Saslow E., Goldfarb O., Goldberg M., Larijani G., Sharrar W., Liouterman L., Camp A., Kolodny E., Samulski J., Leone P. Clinical protocol. Gene Therapy of Canavan disease. AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain Hum. Gene Ther. 13:2002;1391-1412.
77. Jero J., Mhatre A.N., Tseng C.J., Stern R.E., Coling D.E., Goldstein J.A., Hong K., Zheng W.W., Hoque A.T., Lalwani A.K. Cochlear gene delivery through an intact round window membrane in mouse. Hum. Gene Ther. 12:2001;539-548.
78. Kaplitt M.G., Leone P., Samulski R.J., Xiao X., Pfaff D.W., O'Malley K.L., During M.J. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8:1994;148-154.
79. Kay M.A., Manno C.S., Ragni M.V., Larson P.J., Couto L.B., McClelland A., Glader B., Chew A.J., Tai S.J., Herzog R.W., Arruda V., Johnson F., Scallan C., Skarsgard E., Flake A.W., High K.A. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat. Genet. 24:2000;257-261.
80. Kedzierski W., Bok D., Travis G.H. Non-cell-autonomous photoreceptor degeneration in rds mutant mice mosaic for expression of a rescue transgene. J. Neurosci. 18:1998;4076-4082.
81. Kedzierski W., Nusinowitz S., Birch D., Clarke G., McInnes R.R., Bok D., Travis G.H. Deficiency of rds/peripherin causes photoreceptor death in mouse models of digenic and dominant retinitis pigmentosa. Proc. Natl. Acad. Sci. USA. 98:2001;7718-7723.
82. Kho S.T., Pettis R.M., Mhatre A.N., Lalwani A.K. Safety of adeno-associated virus as cochlear gene transfer vector. analysis of distant spread beyond injected cochleae Mol. Ther. 2:2000;368-373.
83. Kobinger G.P., Weiner D.J., Yu Q.C., Wilson J.M. Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat. Biotechnol. 19:2001;225-230.
84. Koeberl D.D., Alexander I.E., Halbert C.L., Russell D.W., Miller A.D. Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA. 94:1997;1426-1431.
85. Kotin R.M., Linden R.M., Berns K.I. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 11:1992;5071-5078.
86. Kumar-Singh R., Farber D.B. Encapsidated adenovirus mini-chromosome- mediated delivery of genes to the retina. application to the rescue of photoreceptor degeneration Hum. Mol. Genet. 7:1998;1893-1900.
87. Lai Y.K., Shen W.Y., Brankov M., Lai C.M., Constable I.J., Rakoczy P.E. Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy. Gene Ther. 9:2002;804-813.
88. Lalwani A.K., Walsh B.J., Reilly P.G., Muzyczka N., Mhatre A.N. Development of in vivo gene therapy for hearing disorders. introduction of adeno-associated virus into the cochlea of the guinea pig Gene Ther. 3:1996;588-592.
89. Lalwani A.K., Han J.J., Walsh B.J., Zolotukhin S., Muzyczka N., Mhatre A.N. Green fluorescent protein as a reporter for gene transfer studies in the cochlea. Hear Res. 114:1997;139-147.
90. Lalwani A., Walsh B., Reilly P., Carvalho G., Zolotukhin S., Muzyczka N., Mhatre A. Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virus. Gene Ther. 5:1998;277-281.
91. Lalwani A.K., Walsh B.J., Carvalho G.J., Muzyczka N., Mhatre A.N. Expression of adeno-associated virus integrated transgene within the mammalian vestibular organs. Am. J. Otol. 19:1998;390-395.
92. Larson P.J., High K.A. Gene therapy for hemophilia B. AAV-mediated transfer of the gene for coagulation factor IX to human muscle Adv. Exp. Med. Biol. 489:2001;45-57.
93. Lau D., McGee L.H., Zhou S., Rendahl K.G., Manning W.C., Escobedo J.A., Flannery J.G. Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2. Invest. Ophthalmol. Vis. Sci. 41:2000;3622-3633.
94. LaVail M.M., Yasumura D., Matthes M.T., Lau-Villacorta C., Unoki K., Sung C.H., Steinberg R.H. Protection of mouse photoreceptors by survival factors in retinal degenerations. Invest. Ophthalmol. Vis. Sci. 39:1998;592-602.
95. LaVail M.M., Yasumura D., Matthes M.T., Drenser K.A., Flannery J.G., Lewin A.S., Hauswirth W.W. Ribozyme rescue of photoreceptor cells in P23H transgenic rats. long-term survival and late-stage therapy Proc. Natl. Acad. Sci. USA. 97:2000;11488-11493.
96. Lebkowski J.S., McNally M.M., Okarma T.B., Lerch L.B. Adeno-associated virus. a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types Mol. Cell. Biol. 8:1988;3988-3996.
97. Lewin A.S., Drenser K.A., Hauswirth W.W., Nishikawa S., Yasumura D., Flannery J.G., LaVail M.M. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Nat. Med. 4:1998;967-971.
98. Liang F.Q., Aleman T.S., Dejneka N.S., Dudus L., Fisher K.J., Maguire A.M., Jacobson S.G., Bennett J. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa. Mol. Ther.: J. Am. Soc. Gene Ther. 4:2001;461-472.
99. Liang F.Q., Aleman T.S., Dejneka N.S., Dudus L., Fisher K.J., Maguire A.M., Jacobson S.G., Bennett J. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa. Mol. Ther. 4:2001;461-472.
100. Liang F.Q., Dejneka N.S., Cohen D.R., Krasnoperova N.V., Lem J., Maguire A.M., Dudus L., Fisher K.J., Bennett J. AAV-mediated delivery of ciliary neurotrophic factor prolongs photoreceptor survival in the rhodopsin knockout mouse. Mol. Ther. 3:2001;241-248.
101. Li Duan M., Bordet T., Mezzina M., Kahn A., Ulfendahl M. Adenoviral and adeno-associated viral vector mediated gene transfer in the guinea pig cochlea. Neuroreport. 13:2002;1295-1299.
102. Lin C.T., Gould D.J., Petersen-Jonest S.M., Sargan D.R. Canine inherited retinal degenerations. update on molecular genetic research and its clinical application J. Small Ani. Pract. 43:2002;426-432.
103. Linden R.M., Ward P., Giraud C., Winocour E., Berns K.I. Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA. 93:1996;11288-11294.
104. Luebke A.E., Foster P.K., Muller C.D., Peel A.L. Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus- and adeno-associated virus-directed gene transfer. Hum. Gene Ther. 12:2001;773-781.
105. Mandel R.J., Spratt S.K., Snyder R.O., Leff S.E. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc. Natl. Acad. Sci. USA. 94:1997;14083-14088.
106. Manno C.S., Chew A.J., Hutchison S., Larson P.J., Herzog R.W., Arruda V.R., Tai S.J., Ragni M.V., Thompson A., Ozelo M., Couto L.B., Leonard D.G., Johnson F.A., McClelland A., Scallan C., Skarsgard E., Flake A.W., Kay M.A., High K.A., Glader B. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood. 101:2002;2963-2972.
107. Martin K.R., Klein R.L., Quigley H.A. Gene delivery to the eye using adeno-associated viral vectors. Methods. 28:2002;267-275.
108. McGee Sanftner L.H., Abel H., Hauswirth W.W., Flannery J.G. Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa. Mol. Ther. 4:2001;622-629.
109. McGee Sanftner L.H., Rendahl K.G., Quiroz D., Coyne M., Ladner M., Manning W.C., Flannery J.G. Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina. Mol. Ther. 3:2001;688-696.
110. McKinnon S.J., Lehman D.M., Tahzib N.G., Ransom N.L., Reitsamer H.A., Liston P., LaCasse E., Li Q., Kornelik R.G., Hauswirth W.W. Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model. Mol. Ther. 5:2002;780-787.
111. Melo L.G., Agrawal R., Zhang L., Rezvani M., Mangi A.A., Ehsan A., Griese D.P., Dell'Acqua G., Mann M.J., Oyama J., Yet S.F., Layne M.D., Perrella M.A., Dzau V.J. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation. 105:2002;602-607.
112. Miyoshi H., Takahashi M., Gage F.H., Verma I.M. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc. Natl. Acad. Sci. USA. 94:1997;10319-10323.
113. Mochizuki H., Hayakawa H., Migita M., Shibata M., Tanaka R., Suzuki A., Shimo-Nakanishi Y., Urabe T., Yamada M., Tamayose K., Shimada T., Miura M., Mizuno Y. An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease. Proc. Natl. Acad. Sci. USA. 98:2001;10918-10923.
114. Mohand-Said S., Deudon-Combe A., Hicks D., Simonutti M., Forster V., Fintz A.C., Leveillard T., Dreyfus H., Sahel J.A. Normal retina releases a diffusible factor stimulating cone survival in the retinal degeneration mouse. Proc. Natl. Acad. Sci. USA. 95:1998;8357-8362.
115. Monahan P.E., Samulski R.J., Tazelaar J., Xiao X., Nichols T.C., Bellinger D.A., Read M.S., Walsh C.E. Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene. Ther. 5:1998;40-49.
116. Mori K., Gehlbach P., Yamamoto S., Duh E., Zack D.J., Li Q., Berns K.I., Raisler B.J., Hauswirth W.W., Campochiaro P.A. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 43:2002;1994-2000.
117. Muramatsu S., Fujimoto K., Ikeguchi K., Shizuma N., Kawasaki K., Ono F., Shen Y., Wang L., Mizukami H., Kume A., Matsumura M., Nagatsu I., Urano F., Ichinose H., Nagatsu T., Terao K., Nakano I., Ozawa K. Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes. Hum. Gene Ther. 13:2002;345-354.
118. Nakai H., Herzog R.W., Hagstrom J.N., Walter J., Kung S.H., Yang E.Y., Tai S.J., Iwaki Y., Kurtzman G.J., Fisher K.J., Colosi P., Couto L.B., High K.A. Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver. Blood. 91:1998;4600-4607.
119. Nakai H., Storm T.A., Kay M.A. Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors. Nat. Biotechnol. 18:2000;527-532.
120. Niederkorn J.Y., Streilein J.W. Induction of anterior chamber-associated immune deviation (ACAID) by allogeneic intraocular tumors does not require splenic metastases. J. Immunol. 128:1982;2470-2474.
121. Olsson J.E., Gordon J.W., Pawlyk B.S., Roof D., Hayes A., Molday R.S., Mukai S., Cowley G.S., Berson E.L., Dryja T.P. Transgenic mice with a rhodopsin mutation (Pro23His). a mouse model of autosomal dominant retinitis pigmentosa Neuron. 9:1992;815-830.
122. Palombo F., Monciotti A., Recchia A., Cortese R., Ciliberto G., La Monica N. Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector. J. Virol. 72:1998;5025-5034.
123. Pierce E.A. Pathways to photoreceptor cell death in inherited retinal degenerations. Bioessays. 23:2001;605-618.
124. Pierce E.A., Avery R.L., Foley E.D., Aiello L.P., Smith L.E. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. USA. 92:1995;905-909.
125. Ponnazhagan S., Erikson D., Kearns W.G., Zhou S.Z., Nahreini P., Wang X.S., Srivastava A. Lack of site-specific integration of the recombinant adeno-associated virus genomes in human cells. Hum. Gene Ther. 8:1997;275-284.
126. Qing K., Mah C., Hansen J., Zhou S., Dwarki V., Srivastava A. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat. Med. 5:1999;71-77.
127. Rabinowitz J.E., Samulski J. Adeno-associated virus expression systems for gene transfer. Curr. Opin. Biotechnol. 9:1998;470-475.
128. Rabinowitz J.E., Samulski R.J. The adeno-associated virus crystal. impact inversely proportional to size Mol. Ther. 6:2002;443-445.
129. Rabinowitz J.E., Rolling F., Li C., Conrath H., Xiao W., Xiao X., Samulski R.J. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J. Virol. 76:2002;791-801.
130. Raisler B.J., Berns K.I., Grant M.B., Beliaev D., Hauswirth W.W. Adeno-associated virus type 2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization. Proc. Natl. Acad. Sci. USA. 99:2002;8909-8914.
131. Rasmussen H., Chu K.W., Campochiaro P., Gehlbach P.L., Haller J.A., Handa J.T., Nguyen Q.D., Sung J.U. Clinical protocol. An open-label, phase I, single administration, dose- escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD). Hum. Gene Ther. 12:2001;2029-2032.
132. Recchia A., Parks R.J., Lamartina S., Toniatti C., Pieroni L., Palombo F., Ciliberto G., Graham F.L., Cortese R., La Monica N., Colloca S. Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector. Proc. Natl. Acad. Sci. USA. 96:1999;2615-2620.
133. Reich S.J., Auricchio A., Hildinger M., Glover E., Maguire A.M., Wilson J.M., Bennett J. Efficient trans-splicing in the retina expands the utility of adeno-associated virus as a vector for gene therapy. Hum. Gene Ther. 14:2003;37-44.
134. Rivolta C., Sharon D., DeAngelis M.M., Dryja T.P. Retinitis pigmentosa and allied diseases. numerous diseases, genes, and inheritance patterns Hum. Mol. Gene. 11:2002;1219-1227.
135. Rolling F., Shen W.Y., Tabarias H., Constable I., Kanagasingam Y., Barry C.J., Rakoczy P.E. Evaluation of adeno-associated virus-mediated gene transfer into the rat retina by clinical fluorescence photography. Hum. Gene Ther. 10:1999;641-648.
136. Rolling F., Shen W.Y., Barnett N.L., Tabarias H., Kanagasingam Y., Constable I., Rakoczy P.E. Long-term real-time monitoring of adeno-associated virus-mediated gene expression in the rat retina. Clin. Exp. Ophthalmol. 28:2000;382-386.
137. Russell D.W., Hirata R.K. Human gene targeting by viral vectors. Nat. Genet. 18:1998;325-330.
138. Russell D.W., Hirata R.K., Inoue N. Validation of AAV-mediated gene targeting. Nat. Biotechnol. 20:2002;658.
139. Sanchez-Pernaute R., Harvey-White J., Cunningham J., Bankiewicz K.S. Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats. Mol. Ther. 4:2001;324-330.
140. Sarra G.M., Stephens C., de Alwis M., Bainbridge J.W., Smith A.J., Thrasher A.J., Ali R.R. Gene replacement therapy in the retinal degeneration slow (rds) mouse. the effect on retinal degeneration following partial transduction of the retina Hum. Mol. Genet. 10:2001;2353-2361.
141. Sarra G.M., Stephens C., Schlichtenbrede F.C., Bainbridge J.W., Thrasher A.J., Luthert P.J., Ali R.R. Kinetics of transgene expression in mouse retina following sub-retinal injection of recombinant adeno-associated virus. Vision Res. 42:2002;541-549.
142. Shen Y., Muramatsu S.I., Ikeguchi K., Fujimoto K.I., Fan D.S., Ogawa M., Mizukami H., Urabe M., Kume A., Nagatsu I., Urano F., Suzuki T., Ichinose H., Nagatsu T., Monahan J., Nakano I., Ozawa K. Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease. Hum. Gene Ther. 11:2000;1509-1519.
143. Skorupa A.F., Fisher K.J., Wilson J.M., Parente M.K., Wolfe J.H. Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice. Exp. Neurol. 160:1999;17-27.
144. Snyder R.O., Miao C.H., Patijn G.A., Spratt S.K., Danos O., Nagy D., Gown A.M., Winther B., Meuse L., Cohen L.K., Thompson A.R., Kay M.A. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat. Genet. 16:1997;270-276.
145. Stavrou P., Good P.A., Broadhurst E.J., Bundey S., Fielder A.R., Crews S.J. ERG and EOG abnormalities in carriers of X-linked retinitis pigmentosa. Eye. 10:1996;581-589.
146. Summerford C., Samulski R.J. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72:1998;1438-1445.
147. Summerford C., Bartlett J.S., Samulski R.J. AlphaVbeta5 integrin. a co-receptor for adeno-associated virus type 2 infection Nat. Med. 5:1999;78-82.
148. Takahashi H., Hirai Y., Migita M., Seino Y., Fukuda Y., Sakuraba H., Kase R., Kobayashi T., Hashimoto Y., Shimada T. Long-term systemic therapy of Fabry disease in a knockout mouse by adeno-associated virus-mediated
149. Ueno T., Matsumura H., Tanaka K., Iwasaki T., Ueno M., Fujinaga K., Asada K., Kato I. Site-specific integration of a transgene mediated by a hybrid adenovirus/adeno-associated virus vector using the Cre/loxP-expression- switching system. Biochem. Biophys. Res. Commun. 273:2000;473-478.
150. Walters R.W., Yi S., Keshavjee S., Brown K.E., Welsh M.J., Chiorini J.A., Zabner J. Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J. Biol. Chem. 21:2001;21.
151. Wang L., Takabe K., Bidlingmaier S.M., Ill C.R., Verma I.M. Sustained correction of bleeding disorder in hemophilia B mice by gene therapy. Proc. Natl. Acad. Sci. USA. 96:1999;3906-3910.
152. Wang L., Nichols T.C., Read M.S., Bellinger D.A., Verma I.M. Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver. Mol. Ther. 1:2000;154-158.
153. Wu P., Xiao W., Conlon T., Hughes J., Agbandje-McKenna M., Ferkol T., Flotte T., Muzyczka N. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J. Virol. 74:2000;8635-8647.
154. Xie Q., Bu W., Bhatia S., Hare J., Somasundaram T., Azzi A., Chapman M.S. The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc. Natl. Acad. Sci. USA. 99:2002;10405-10410.
155. Yan Z., Zhang Y., Duan D., Engelhardt J.F. Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy. Proc. Natl. Acad. Sci. USA. 97:2000;6716-6721.
156. Yang G.S., Schmidt M., Yan Z., Lindbloom J.D., Harding T.C., Donahue B.A., Engelhardt J.F., Kotin R., Davidson B.L. Virus-mediated transduction of murine retina with adeno-associated virus. effects of viral capsid and genome size J. Virol. 76:2002;7651-7660.
157. Zabner J., Seiler M., Walters R., Kotin R.M., Fulgeras W., Davidson B.L., Chiorini J.A. Adeno-associated virus type 5 (AAV2) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J. Virol. 74:2000;3852-3858.
158. Zack D.J. Birth and death in the retina. more related than we thought? Neuron. 23:1999;411-412.